Elizabeth Jaffee

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Elizabeth Jaffee
Mar 21, 2025, 17:04 | Blog
Alicia Zhou: Fighting for the future of cancer science amid NIH disruptions
Alicia Zhou, CEO of Cancer Research Institute, shared a post on LinkedIn: Recent National Institutes…
Jan 18, 2025, 12:39 | Insight
Anirban Maitra: New paper from Johns Hopkins Kimmel Cancer Center on pancreatic cancer
Anirban Maitra, Director of the Sheikh Ahmed Pancreatic Cancer Research Center, shared a post on…
Oct 16, 2024, 11:47 | Blog
Allison Institute Symposium Highlights Spatial Biology Innovations and $5M Donation to Boost Research
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted…
Sep 14, 2024, 06:36 | Societies
13 Posts Not To Miss From CICON24
The Eighth International Cancer Immunotherapy Conference (CICON24) took place from September 8 to 11, 2024,…
Jul 31, 2024, 07:02 | Blog
Get to know the chair of the President’s Cancer Panel, Dr. Elizabeth Jaffee – NCI
In 1971, Richard Nixon, the President of USA, signed the National Cancer Act, which established…
Jul 30, 2024, 14:34 | Insight
Get to know the chair of the President’s Cancer Panel, Dr. Elizabeth Jaffee - NCI
National Cancer Institute shared on LinkedIn: ”Get to know the chair of the President’s Cancer Panel,…
Jun 20, 2024, 15:43 | Blog
Getting to know Elizabeth Jaffee - President's Cancer Panel
President's Cancer Panel shared a post on X: "Want to get to know the Panel…
May 13, 2024, 05:26 | Blog
AACR - Joint workshop on Trial Designs for Treatment Regimens with Multiple Phases
AACR shared a post on X: "AACR Past President Elizabeth M. Jaffee and FDA oncology's Harpreet…
Apr 20, 2024, 19:03 | Blog
How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases - FDA Oncology
FDA Oncology shared on X/Twitter: "How Much is Enough? Trial Designs for Treatment Regimens with…
Apr 12, 2024, 17:36 | Insight
Mark Yarchoan: Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 in 2L HCC presented at AACR24
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared on X: "Multicenter P1/2 trial of…
All: 10 Posts: 1 - 100
Special Coverage